Crossmark

Individuals with a fragility fracture and a prescription for bone active medication have a positive perception of the medication but do not associate it with fracture risk reduction

Crossref DOI link: https://doi.org/10.1007/s11657-024-01449-5

Published Online: 2024-10-01

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Sale, Joanna E. M. https://orcid.org/0000-0003-0389-3038
Theivendrampillai, Suvabna

Linton, Denise

Porteous, Judy
License Information

Text and Data Mining valid from 2024-10-01

Version of Record valid from 2024-10-01
More Information

Article History

Received: 18 March 2024

Accepted: 12 September 2024

First Online: 1 October 2024

Declarations

:

: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

: Informed consent was obtained from all individual participants included in the study.

: All authors have provided consent for publication of this manuscript.

: None.

Document is current

Any future updates will be listed below